AGM
EDIT icon

Alpine Global Management’s Editas Medicine EDIT Stock Holding History

Alpine Global Management’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-13,380
Closed -$119K – 234
2022
Q4 		$119K Buy
+13,380
New +$147K 0.04% 171

Other funds holding EDIT

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Alpine Global Management's EDIT Position: Q1 2023 in Review

Alpine Global Management sold out of Editas Medicine (EDIT) in Q1 2023, closing a stake of 13,380 shares — an estimated $119K sold.

Alpine Global Management first reported a position in EDIT in Q4 2022 and held it in 1 quarter. The position peaked at $119K in Q4 2022. 234 funds tracked by Wall St. Rank hold EDIT as of Q1 2023.

  • Alpine Global Management reported no remaining Editas Medicine position as of Q1 2023 after selling out during the quarter.
  • Alpine Global Management sold 13,380 Editas Medicine shares in Q1 2023, an estimated $119K.
  • Alpine Global Management first reported a position in Editas Medicine in Q4 2022 and held it in 1 quarter.
  • Alpine Global Management's Editas Medicine position peaked at $119K in Q4 2022.
  • 234 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2023.

Based on Alpine Global Management's 13F filing for Q1 2023, filed 15 May 2023.